ACTUATE THERAPEUTICS, INC.(ACTU)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ACTU Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for ACTUATE THERAPEUTICS, INC. (ACTU), a Healthcare sector company. ACTU is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ACTU by reported 13-F value include BIOS Capital Management, Voss Capital, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ACTU trades on the Nasdaq exchange and files with the SEC under CIK 1652935. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACTU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACTUATE THERAPEUTICS, INC. directly from SEC EDGAR.
Net Income
Q2 2026
$-4.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
+18.5% YoYOperating Income
+10.6% YoYEPS (Diluted)
+67.5% YoYTotal Assets
+50.6% YoYOp. Cash Flow
+12.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Net Income | $-22.2M +18.5% | $-27.3M -10.3% | $-24.7M | — |
| Operating Income | $-22.5M +10.6% | $-25.2M -0.7% | $-25.0M | — |
| EPS (Diluted) | $-1.06 +67.5% | $-3.26 +81.1% | $-17.24 | — |
| Total Assets | $14.0M +50.6% | $9.3M +211.1% | $3.0M | — |
| Operating Cash Flow | $-19.2M +12.1% | $-21.8M -1.0% | $-21.6M | — |
Get alerted when ACTU's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ACTUATE THERAPEUTICS, INC. including:
Top Institutional Holders of ACTU
BIOS Capital Management, LP
$15.4M10,049,996 shVoss Capital, LP
$2.6M1,725,000 shVANGUARD CAPITAL MANAGEMENT LLC
$602.0K393,433 shAQR CAPITAL MANAGEMENT LLC
$195.1K127,493 shGEODE CAPITAL MANAGEMENT, LLC
$172.2K112,554 shTexas Capital Bank Wealth Management Services Inc
$157.0K102,612 shPalogic Value Management, L.P.
$153.0K100,000 shMILLENNIUM MANAGEMENT LLC
$147.9K96,684 shBlackRock, Inc.
$137.8K90,035 shABS Direct Equity Fund LLC
$112.0K73,186 sh
| Fund | Value | Shares |
|---|---|---|
| BIOS Capital Management, LP | $15.4M | 10,049,996 |
| Voss Capital, LP | $2.6M | 1,725,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $602.0K | 393,433 |
| AQR CAPITAL MANAGEMENT LLC | $195.1K | 127,493 |
| GEODE CAPITAL MANAGEMENT, LLC | $172.2K | 112,554 |
| Texas Capital Bank Wealth Management Services Inc | $157.0K | 102,612 |
| Palogic Value Management, L.P. | $153.0K | 100,000 |
| MILLENNIUM MANAGEMENT LLC | $147.9K | 96,684 |
| BlackRock, Inc. | $137.8K | 90,035 |
| ABS Direct Equity Fund LLC | $112.0K | 73,186 |
More Healthcare Companies
View all Healthcare →Put ACTU on your watchlist
Track score changes the day ACTUATE THERAPEUTICS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACTU a good stock to buy?
13F Pro's AI-powered analysis of ACTUATE THERAPEUTICS, INC. (ACTU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACTU are available on the ACTU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ACTU is classified as a small company.
Which hedge funds own ACTU?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACTU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ACTUATE THERAPEUTICS, INC.'s investment landscape.